The Use of Probiotics to Evaluate Colonization With Antimicrobial Resistant Bacteria
Status: | Completed |
---|---|
Conditions: | Infectious Disease |
Therapuetic Areas: | Immunology / Infectious Diseases |
Healthy: | No |
Age Range: | 18 - Any |
Updated: | 12/19/2018 |
Start Date: | February 2012 |
End Date: | December 2013 |
The Use of the Probiotic, Lactobacillus Rhamnosus GG to Evaluate Colonization With Antimicrobial Resistant Bacteria in High Risk Patients
The purpose of this study is to evaluate the effectiveness of bacteria called Lactobacillus
GG, a Probiotic, in preventing the growth of resistant bacteria in the digestive tract in
patients on a ventilator.
GG, a Probiotic, in preventing the growth of resistant bacteria in the digestive tract in
patients on a ventilator.
Inclusion Criteria:
- Adults ≥ 18 years old
- Admission to the Medical ICU
- Expected to be on Mechanical Ventilation through an endotracheal tube for >48 hours
Exclusion Criteria:
- Pregnancy
- Immunosuppression
- Prosthetic valve or vascular graft
- Cardiac trauma
- Pancreatitis
- History of rheumatic fever
- Endocarditis or congenital cardiac abnormality
- Gastroesophageal or intestinal injury or foregut surgery during the current admission
- Oropharyngeal mucosal injury
- Placement of a tracheostomy
We found this trial at
1
site
660 S Euclid Ave
Saint Louis, Missouri 63110
Saint Louis, Missouri 63110
(314) 362-5000
Washington University School of Medicine Washington University Physicians is the clinical practice of the School...
Click here to add this to my saved trials